Inpeco and Genes Laboratories Join Forces to Advance Clinical Laboratory Automation in Korea
Novazzano, Switzerland – [28.10.2025] –Inpeco S.A., the global leader in Total Laboratory Automation, has signed a distribution agreement with Genes Laboratories, a subsidiary of GC Holdings, to strengthen its presence in the Korean diagnostic market.
Under this partnership, Genes Laboratories will distribute and provide technical support for Inpeco’s FlexLab™ X and ProTube™ automation solutions in South Korea. The agreement builds upon the successful implementation of Inpeco’s largest Total Laboratory Automation (TLA) system in Asia, already operating at GC Labs, a GC Holdings subsidiary. The system, which integrates multiple analyzers from various vendors, ranks among the world’s top ten in total track length and achieves the highest specimen throughput per hour in the Asia-Pacific region. Its excellent performance and reliability have set a new benchmark for automation in clinical laboratories across Korea.
“The successful implementation of the GC Labs project has clearly demonstrated the growth potential of the Korean market,” said Riccardo Triunfo, CEO of Inpeco S.A. “We are excited to introduce our visionary automation technology — combining open connectivity with full sample traceability — to one of Asia’s most advanced healthcare environments. Our collaboration with Genes Labs will empower clinical laboratories to increase efficiency, improve result accuracy, and deliver better patient outcomes. This partnership marks an important step in our long-term commitment to Korea.”
A representative from Genes Laboratories added: “By formalizing this partnership with Inpeco, we aim to accelerate the adoption of laboratory automation in Korea, leveraging the proven excellence demonstrated at GC Labs. Together, we will set new standards for operational efficiency and quality in diagnostic testing.”
Through this collaboration, Inpeco further expands its global network, reinforcing its mission to bring complete sample traceability and open automation to laboratories worldwide — driving innovation, quality, and better healthcare outcomes for all.
About Inpeco
Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to support secure test results and increase productivity in clinical laboratories around the world. To date, more than 2800 Inpeco systems have been shipped to 78 countries. Inpeco also provides automation for anatomical pathology labs and is developing solutions for blood banks and life sciences applications. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales offices in Europe, China, and the United States.
For more information, please visit: www.inpeco.com
About Genes Laboratories (Genes Labs)
Genes Laboratories is emerging as a leading force in the field of molecular diagnostics and solutions, dedicated to advancing innovation and improving healthcare through research and product development. Since its establishment in 2008, Genes Laboratories has specialized in manufacturing molecular IVD products — from raw materials to final diagnostic kits.
Driven by a team of experienced researchers and industry experts, Genes Laboratories operates with a strong commitment to safety, efficacy, and Korean quality standards. Its integrated approach combines modern biotechnology with rigorous quality control, ensuring that each product meets both scientific and consumer expectations.
As a recognized affiliated company of Green Cross Corporation, a global healthcare group based in Korea, Genes Laboratories aims to expand its presence in the Korean market through collaboration with Inpeco. The company remains steadfast in its mission to build a strong partnership with Inpeco and achieve continued success in the Total Laboratory Automation market in Korea.